IPO

As AI valuations soar and IPOs loom, one veteran wealth manager warns of a familiar pattern. Are we witnessing innovation or another dot-com-style bubble?

A new study reveals over 211 fake legal cases, largely AI-generated, have infiltrated Canadian courts, threatening justice and hitting the vulnerable hardest.

As AI coding tools create a 'visibility crisis,' a new platform aims to restore order by giving teams a real-time map of their evolving software.

Jaguar Uranium re-analyzes old drill cores in Colombia, hunting for rare earths in a bid to create a new, non-Chinese critical minerals hub for the West.

Chinese lifestyle group Atour surpasses growth targets with a 35% revenue jump, fueled by hotel expansion and a booming retail business.

Tencent Music posts record profits and a huge dividend, but a shrinking user base and a new policy to hide key metrics leave investors wary.

The global consulting firm launches a tech-driven Valuations practice, aiming to deliver faster, AI-powered insights in a volatile economic landscape.

Seoul's K-Royal Cultural Festival blends history with high-tech, offering an immersive journey into Korea's majestic past. Bookings are now open.

Pono Capital Four has closed a $120M IPO, launching its search for a tech unicorn in a resurgent but challenging SPAC market led by a veteran sponsor.

The newly public BlockchAIn Inc. (AIB) launches with a unique strategy: powering the AI gold rush while also owning a college sports recruitment platform.

As executives head to a key summit, all eyes are on OPENLANE's plan to navigate a used car market ripe with digital opportunity and economic risk.

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

As FullPAC sponsors the 2026 Pollie Awards, its focus on AI and a planned public listing reveal a strategy to reshape how elections are won.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

With a unique Nasdaq listing plan and hydrogen-ready tech, Israeli firm Turbogen aims to disrupt the multi-billion dollar U.S. energy market.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

CT REIT declared its latest monthly distribution, reinforcing its reputation for reliability. We dig into the numbers and what they mean for investors.

South Korea's hybrid airline is removing seats to boost legroom, betting that passenger comfort will outweigh the loss in capacity. Will it pay off?

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.